© 2002 by the American Diabetes Association, Inc.
The Prevalence of Hypertension and Utilization of Antihypertensive Therapy in a District Diabetes PopulationFrom the Wolverhampton Diabetes Centre, New Cross Hospital, Wolverhampton, U.K
Hypertension and antihypertensive treatment (AHT) impact on diabetes vascular outcomes and systolic blood pressure (SBP) probably confers a greater risk than diastolic blood pressure (1,2). Recent guidelines promote low intervention thresholds and target blood pressures (<130140/8085 mmHg) without considering the impact on clinical service provision (3,4). Using SBP targets, we describe hypertension prevalence, AHT utilization, and efficacy in a large district diabetes population.
We studied 6,485 of 7,123 registered adults (
|
| |||||||||||||||||||||||||||